The propofol infusion syndrome in infants and children: Can we predict the risk?

Current Opinion in Anaesthesiology

Volumn 15, Issue 3, 2002, Pages 339-342

  Bray, Robin J ^a  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROPOFOL;

ANESTHESIA INDUCTION; DIALYSIS; DRUG INDUCED DISEASE; FATTY LIVER; HEART FAILURE; HUMAN; HYPERLIPIDEMIA; METABOLIC ACIDOSIS; MORTALITY; MUSCLE INJURY; PEDIATRIC ANESTHESIA; PRIORITY JOURNAL; REVIEW; SEDATION; SYNDROME;

EID: 0036264093     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001503-200206000-00010     Document Type: Review

References (46)

1. ICI 35868, a new intravenous induction agent
2. Haemodynamic effects of infusions of diisopropyl phenol (ICl 35868) during nitrous oxide anaesthesia in man
3. Propofol infusion for sedation in the intensive care unit: Preliminary report
4. Propofol as an induction agent in pediatric anesthesia. A preliminary clinical study
5. Propofol infusion for pediatric sedation. Report of a case and review of the literature
6. Propofol infusion for sedation of children
7. Propofol (Diprivan) bivirkninger
8. Diprivan intensive care sedation in children
9. An audit of sedation, analgesia and muscle relaxation in paediatric intensive care in the United Kingdom
10. Metabolic acidosis and fatal myocardial failure after propofol infusion in children: Five case reports
11. Propofol infusion in children
12. Serious adverse effects and fatalities in children associated with the use of propofol (Diprivan) for sedation
13. ICI's Diprivan (propofol) anesthetic has no direct link to pediatric deaths in ICUs, FDA advisory committee finds; FDA asks ICI to pursue pediatric indication
14. Propofol infusion in children
15. Fatal myocardial failure associated with a propofol infusion in a child
16. Fatal metabolic acidosis in a pediatric patient receiving an infusion of propofol in the intensive care unit: Is there a relationship?
17. Fatal side-effects of continuous propofol infusion in children may be related to malignant hyperthermia
18. Propofol bashing: The time to stop is now!
19. A pharmacokinetically based propofol dosing strategy for sedation of the critically ill, mechanically ventilated pediatric patient
20. A comparison of propofol and other sedative use in paediatric intensive care in the United Kingdom
21. Metabolic, biochemical and haemodynamic effects of infusion of propofol for long-term sedation of children undergoing intensive care
22. Propofol in paediatric intensive care
23. Fatal myocardial failure associated with a propofol infusion in a child
24. Propofol in paediatric intensive care: Further evaluation is justified
25. Propofol infusion syndrome in children
26. Rhabdomyolysis and pulmonary hypertension in a child, possibly due to long-term high-dose propofol infusion
27. Lactic acidemia and bradyarrhythmia in a child sedated with propofol
28. Rhabdomyolysis and hypoxia associated with prolonged propofol infusion in children
29. Propofol toxicity in critically ill pediatric patients: Show us the proof
30. Propofol in paediatric intensive care: Further evaluation is justified
31. Propofol-infusion syndrome in children
32. Propofol-infusion syndrome in children
33. Rare events often happen infrequently: Propofol complications revisited
34. Propofol-infusion syndrome in children
35. Propofol infusion in children
36. Short-term propofol infusions in children
37. Impaired fatty acid oxidation in propofol infusion syndrome
38. Propofol impairment of mitochondrial respiration in isolated perfused guinea pig hearts determined by reflectance spectrometry
39. Propofol. An overview of its pharmacology and a review of its clinical efficiency in intensive care sedation
40. Death related to propofol use in an adult patient
41. Propofol-associated rhabdomyolysis with cardiac involvement in adults: Chemical and anatomic findings
42. Long-term propofol infusion and cardiac failure in adult head-injured patients
43. Metabolic acidosis associated with a new formulation of propofol
44. Propofol (Diprivan) infusion: Sedation in children aged 16 years or younger contra-indicated